It seems to be an interesting direction for future work to test the effect of ALA-PDT on the EGFR expression by glioma cells as testing other cancer cells has demonstrated the potential to lead to a reduction in the EGFR levels [280]. The gene discussed is EGFR; the disease is central nervous system cancer.